Reference : New synthetic opioids: Part of a new addiction landscape.
Scientific journals : Article
Social & behavioral sciences, psychology : Neurosciences & behavior
http://hdl.handle.net/10993/36603
New synthetic opioids: Part of a new addiction landscape.
English
Karila, Laurent [> >]
Marillier, Maude [> >]
Chaumette, Boris [> >]
Billieux, Joël mailto [University of Luxembourg > Faculty of Language and Literature, Humanities, Arts and Education (FLSHASE) > Integrative Research Unit: Social and Individual Development (INSIDE)]
Nicolas, Franchitto [> >]
Amine, Benyamina [> >]
In press
Neuroscience and biobehavioral reviews
Yes (verified by ORBilu)
International
0149-7634
1873-7528
United States
[en] AH-7921 ; Adverse effects ; Fatalities ; Fentanyl ; MT-45 ; New psychoactive substances ; Psychiatric complications ; Somatic complications ; Substance use disorder ; Synthetic opioids ; U-47700
[en] Synthetic opioids (SO) are a major risk for public health across the world. These drugs can be divided into 2 categories, pharmaceutical and non-pharmaceutical fentanyls. A new generation of SO has emerged on the drug market since 2010. North America is currently facing an opioid epidemic of morbi-mortality, caused by over-prescription of opioids, illegally diverted prescribed medicines, the increasing use of heroin, is and the emergence of SO. Furthermore, this opioid crisis is also seen in Europe. SO are new psychoactive substances characterized by different feature such as easy availability on the Internet, low price, purity, legality, and lack of detection in laboratory tests. They have not been approved or are not recommended for human use. Opioid misuse is associated with somatic and psychiatric complications. For many substances, limited pharmacological information is available, increasing the risk of harmful adverse events. Health actors and the general population need to be clearly informed of the potential risks and consequences of the diffusion and use of SO.
http://hdl.handle.net/10993/36603
10.1016/j.neubiorev.2018.06.010
Copyright (c) 2018 Elsevier Ltd. All rights reserved.

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Limited access
Karila_NBR_2018.pdfPublisher postprint784.42 kBRequest a copy

Bookmark and Share SFX Query

All documents in ORBilu are protected by a user license.